Russell Investments Group, Ltd. Biocryst Pharmaceuticals Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 15,025 shares of BCRX stock, worth $114,190. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,025

Previous 83,253 81.95%

Holding current value

$114,190

Previous $514,000 77.82%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$6.41 - $8.69 $437,341 - $592,901	-68,228 Reduced 81.95%	15,025 $114,000
Q2 2024 Aug 08, 2024	BUY	$4.13 - $6.79 $101,300 - $166,545	24,528 Added 41.77%	83,253 $514,000
Q1 2024 May 08, 2024	BUY	$4.89 - $7.65 $191,712 - $299,918	39,205 Added 200.85%	58,725 $298,000
Q4 2023 Feb 05, 2024	SELL	$4.98 - $6.77 $6,170 - $8,388	-1,239 Reduced 5.97%	19,520 $116,000
Q3 2023 Nov 13, 2023	SELL	$6.71 - $7.92 $187,349 - $221,134	-27,921 Reduced 57.36%	20,759 $146,000
Q2 2023 Aug 10, 2023	SELL	$6.96 - $8.81 $859,455 - $1.09 Million	-123,485 Reduced 71.72%	48,680 $342,000
Q1 2023 May 09, 2023	BUY	$7.94 - $11.84 $168,105 - $250,676	21,172 Added 14.02%	172,165 $1.44 Million
Q4 2022 Feb 08, 2023	BUY	$10.5 - $14.2 $250,089 - $338,215	23,818 Added 18.73%	150,993 $1.73 Million
Q3 2022 Nov 04, 2022	SELL	$10.79 - $14.81 $1.3 Million - $1.78 Million	-120,347 Reduced 48.62%	127,175 $1.6 Million
Q2 2022 Jul 29, 2022	BUY	$7.89 - $17.88 $1.32 Million - $2.99 Million	167,096 Added 207.76%	247,522 $2.62 Million
Q1 2022 May 05, 2022	BUY	$11.56 - $19.76 $905,876 - $1.55 Million	78,363 Added 3798.5%	80,426 $1.31 Million
Q3 2021 Nov 08, 2021	BUY	$14.21 - $17.65 $29,315 - $36,411	2,063 New	2,063 $29,000
Q2 2020 Aug 05, 2020	SELL	$1.9 - $5.61 $307,433 - $907,737	-161,807 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$1.6 - $4.11 $276,668 - $710,692	-172,918 Reduced 51.66%	161,807 $323,000
Q4 2019 Jan 29, 2020	BUY	$1.59 - $3.45 $273,766 - $594,021	172,180 Added 105.93%	334,725 $1.15 Million
Q3 2019 Nov 01, 2019	BUY	$2.5 - $3.73 $406,362 - $606,292	162,545 New	162,545 $466,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Biocryst Pharmaceuticals Inc Transaction History